STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABEO
  4. [8-K] Abeona Therapeutics Inc. Reports Material Event

[8-K] Abeona Therapeutics Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ABEO logo
Abeona Therapeut

NASDAQ:ABEO

ABEO Rankings

#5523 Ranked by Market Cap
N/A Ranked by Dividends

ABEO Latest News

Jul 15, 2025
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
Jul 14, 2025
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
Jul 2, 2025
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
Jul 1, 2025
Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy
Jul 1, 2025
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO Latest SEC Filings

Jul 10, 2025
[Form 4] Abeona Therapeutics Inc. Insider Trading Activity
Jul 10, 2025
[Form 4] Abeona Therapeutics Inc. Insider Trading Activity
Jul 10, 2025
[Form 4] Abeona Therapeutics Inc. Insider Trading Activity
Jul 10, 2025
[Form 4] Abeona Therapeutics Inc. Insider Trading Activity
Jul 10, 2025
[Form 4] Abeona Therapeutics Inc. Insider Trading Activity

ABEO Stock Data

299.27M
48.17M
5.45%
76.5%
5.8%
Biotechnology
Pharmaceutical Preparations
Link
United States
CLEVELAND